A Double-Blinded, Placebo-Controlled, Randomized, 2 Period, Crossover Phase 1/2a Study to Test the Safety and Efficacy of Advair HFA (Salmeterol and Fluticasone) in Resting and Exercising Healthy and High Altitude Pulmonary Edema (HAPE) Predisposed Subjects
Primary Objective
Investigators at the University of Colorado are conducting research on the ability to exercise under high altitude (low oxygen) conditions. The study is looking at the safety and effects on exercise of a high dose of an inhaled asthma medication (salmeterol/fluticasone, or Advair?) on exercise performance while breathing low-oxygen air.
Description
The study involves two separate study periods of 12 days each, where you will: • Take the study drug or placebo through a puffer for 7 days. You will not know which drug you are taking during which period • Wear a continuous heart monitor for 12 days • Have blood tests drawn during 5 visits • Complete an exercise performance test while breathing air that has a low oxygen levels (similar to the air at high altitude)
Details
Locations
CTRC Inpatient
Outpatient CTRC
Principal Investigator
James Maloney
Study ID
Protocol Number: 23-0463
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers